Condensed Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating activities
Net loss	$ (1,306,178)	$ (1,579,820)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	84,384	254,029
Non-cash interest expense	123,288	124,658
Non-cash operating lease expense	19,147
Change in operating assets and liabilities:
Accounts receivable	(91,117)	(778,833)
Prepaid expenses and other assets	333,307	222,045
Inventories	(87,064)	(106,936)
Accounts payable and accrued expenses	440,012	343,596
Accrued compensation	(493,918)	(1,058,129)
Operating lease liabilities	(19,370)
Net cash used in operating activities	(997,509)	(2,579,390)
Financing activities
Proceeds from the issuance of common stock pursuant to the ESPP	24,999
Net cash provided by financing activities	24,999	7,542,719
Net (decrease) increase in cash and cash equivalents	(972,510)	4,963,329
Cash and cash equivalents at beginning of period	13,596,600	4,739,426
Cash and cash equivalents at end of period	$ 12,624,090	9,702,755
Supplemental disclosure of non-cash investing and financing activities
Offering costs in accounts payable and accrued expenses		20,926
February 2024 Offering [Member]
Financing activities
Proceeds from Issuance Initial Public Offering		6,718,211
Payment of Offering costs		(426,292)
March 2024 Warrant [Member]
Financing activities
Proceeds from Warrant Amendment, net of issuance costs		$ 1,250,800